Platelet Rich Plasma in Erectile Dysfunction A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

Authors

  • Jihad Anad Khalef
  • Shaymaa Abed Hasan
  • Ahmed Nazar

DOI:

https://doi.org/10.37506/ijfmt.v17i1.18906

Keywords:

Platelet rich plasma, erectile dysfunction, p-shot, intracavernosal injection

Abstract

Background: The studies postulate that platelet-rich plasma (PRP) injections improve key elements of
neovascualrity to erectile dysfunction (ED).
Aim: Double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of PRP injections in
patients with mild and moderate ED. Exclusion criteria were patient undergo sever ED
Methods: Study is accomplished in Alnuman teaching hospital 2019 and 2022 over 59 patients were complaining
mild to moderate ED, four sessions of P-shot 2 weeks apart each session.
Results: In period 3, 6 months’ interval, a response was achieved by 35/42 (83%) patients in the PRP group
compared to 5/17 (29%) in the placebo group.
Key words: Platelet rich plasma, erectile dysfunction, p-shot, intracavernosal injection.

Author Biographies

  • Jihad Anad Khalef

    Assistant Professor of Urology, Department of Surgery Faculty of Medicine, Iraqia university

  • Shaymaa Abed Hasan

    Assistant Professor of Gynecology, Department of surgery faculty of medicine, Iraqia university,

  • Ahmed Nazar

    Professor ofUrology, Department of Surgery Faculty of Medicine, Iraqia university

Downloads

Published

2022-12-21

Issue

Vol. 17 No. 1 (2023): Indian Journal of Forensic Medicine and Toxicology

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

https://creativecommons.org/licenses/by-nc/2.0/deed.en

How to Cite

Platelet Rich Plasma in Erectile Dysfunction A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. (2022). Indian Journal of Forensic Medicine & Toxicology, 17(1), 120-122. https://doi.org/10.37506/ijfmt.v17i1.18906